A preview is not available for this record, please engage by choosing from the available options ‘download’ or ‘view’ to engage with the material
Description
To find a new way to make genomic insights more accessible, Intel teamed up with a premier research institute, the Berlin Institute of Health at Charité (Charité BIH), and precision medicine focused bioinformatics software developer, Sentieon. This collaboration developed an optimized analytic pipeline that performed analysis on long-read next-generation sequencing (NGS) data using standard data center CPUs from Intel. The proof-of-concept pipeline built by Sentieon cut the standard time-to-result by more than 14x. In further testing, 4th Generation Intel® Xeon® Scalable processors showed a 21% advantage in speed over 3rd Generation Intel® Xeon® Scalable processors. This offers tremendous potential to bring economies of scale to bioinformatics as each successive generation of Intel technology helps make genomic analysis software faster and more efficient.